XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Related parties
 9 Months Ended
May 31, 2025
Related Party Transactions [Abstract]  
Related parties Related parties
The Company has a long-term pharmaceutical distribution agreement with Cencora pursuant to which the Company sources branded and generic pharmaceutical products from Cencora. Additionally, Cencora receives sourcing services for generic pharmaceutical products.

Related party transactions with Cencora (in millions):
 Three months ended May 31,Nine months ended May 31,
 2025202420252024
Purchases, net$19,727 $18,181 $58,843 $54,296 

 May 31, 2025August 31, 2024
Trade accounts payable, net of receivables$8,943 $9,259 

On March 6, 2025, the Company entered into the Merger Agreement with Parent, Merger Sub, a wholly owned subsidiary of Parent, and certain other affiliates of Parent.

In connection with the Merger Agreement, the Company’s Executive Chairman, Stefano Pessina, and his holding company, who in the aggregate own approximately 17% of the Company’s shares of outstanding common stock, entered into a voting agreement in favor of Parent and the Company and a reinvestment agreement with Parent and certain other affiliates of Parent. Under these agreements, Mr. Pessina and his holding company will vote all of their shares of the Company’s common stock in favor of the Merger Agreement (consistent with obligations under his existing shareholder’s agreement), subject to certain terms and conditions contained therein, and will reinvest all of their cash consideration received in the transaction, in addition to an incremental cash investment, into the acquiring company. Each of Mr. Pessina and John Lederer, one of the Company’s directors and an affiliate of Sycamore Partners Management, L.P., the beneficial owner of Parent and Merger Sub, were recused from the deliberations, evaluation and approval of the transaction by the Company’s Board of Directors. See Note 1. Accounting policies for further information.